Don't just mask the symptom—re‑program the receptor. PainRelief targets 8 synergistic pathways to slash inflammation and calm overactive nerve channels in as little as 21 minutes.
Experience Clinical Grade Relief →✓ 10,000+ satisfied customers
Stop the "emergency broadcast" of pain by targeting TRPV1 receptors for immediate desensitization.
Targets TRPV1 receptors for rapid desensitization. Eugenol provides natural anesthetic effect comparable to 30% lidocaine—relief in ~21 minutes.
Boosts endorphin tone by slowing enkephalin breakdown, raising pain threshold while improving mood.
Chronic inflammation creates fibrin plugs that shield damaged tissue. We dissolve them so actives can penetrate deep.
Proteolytic enzyme that clears fibrin, reduces swelling by up to 51%, and increases curcumin tissue entry by 2x.
Boosts systemic absorption of curcumin by 30‑fold (3000%).
Flood inflammatory pathways with clinical‑grade inhibitors to shut down LTB₄ and PGE₂ production.
The gold standard duo. Simultaneously inhibits COX‑2 and 5‑LOX, reducing IL‑6 and TNF‑α.
Natural aspirin analogue. Sustained joint and back relief without gastric irritation.
Chronic pain "teaches" nerves to stay sensitive. We lock the gate on overactive NMDA receptors.
Targets PPAR‑α to stabilize mast cells and microglia. 50% reduction in neuropathic pain scores.
Modulate NMDA receptors to lower central sensitization—"turning down the volume" on chronic nerve pain.
For acute relief: 4 capsules. For chronic issues: 4 capsules/day for 14 days to allow PEA and Agmatine to fully re‑balance nerve receptors, increasing pain threshold by 34%.
| Capability | Standard NSAIDs | PainRelief |
|---|---|---|
| Pathway Coverage | 1 (COX‑2) | 8 synergistic pathways |
| Nerve/Neuropathic Support | None | PEA + NMDA gatekeeping |
| Tissue Penetration | Passive | Bromelain fibrin‑breakers |
| Gut Safety | High ulcer risk | Zero gastric irritation |
8 pathways. Clinical potency. No mental fog. The only formula that addresses the biological "memory" of pain.
Shop PainRelief Now →*Based on pilot study data: 21‑min onset & +34% pressure‑pain threshold.
